Studies aimed at elucidating the mechanisms by which CYB5R4 might be mediating the pathogenesis of diabetes, and the assessment of potential interacting partners in vitro and in vivo would further facilitate the development of new therapeutic avenues. This evidence concerns the gene CYB5R4 and diabetes mellitus.